A leading Chinese pharmaceutical company specializing in biopharmaceuticals, vaccines, and medical devices. Investors monitor Sinopharm for its dominant position in China's healthcare market and its role in COVID-19 vaccine distribution.
No congressional trades have been disclosed for Sinopharm Group Co. Ltd. (SHTDY) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.